Literature DB >> 32320854

The combination of disulfiram and copper for cancer treatment.

Hong Li1, Jingyu Wang1, Chunfu Wu1, Lihui Wang2, Zhe-Sheng Chen3, Wei Cui4.   

Abstract

Disulfiram (DSF) is a thiuram derivative that was developed to treat alcoholism but was also found to have antitumor activity. Copper (Cu), as a trace metal, has important roles in the body. Numerous studies have shown that the combination of DSF and copper (DSF/Cu) greatly enhances its antitumor efficacy. Given that the efficacy of DSF is well established and its safety profile is understood, repurposing DSF as a new anticancer drug is a promising strategy. Here, we summarize the pharmacological effects of DSF and the role of Cu in cancer, and focus on the antitumor effect of DSF/Cu, especially the mechanisms involved in enhancing drug sensibility by targeting specific molecules. We also provide rational strategies for using DSF as a cancer therapy.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32320854     DOI: 10.1016/j.drudis.2020.04.003

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  17 in total

Review 1.  Ferroptosis as a mechanism of non-ferrous metal toxicity.

Authors:  Michael Aschner; Alexey A Tinkov; Anatoly V Skalny; Airton C Martins; Anton I Sinitskii; Marcelo Farina; Rongzhu Lu; Fernando Barbosa; Yordanka G Gluhcheva; Abel Santamaria
Journal:  Arch Toxicol       Date:  2022-06-21       Impact factor: 6.168

Review 2.  Emerging roles of cystathionine β-synthase in various forms of cancer.

Authors:  Kelly Ascenção; Csaba Szabo
Journal:  Redox Biol       Date:  2022-05-10       Impact factor: 10.787

3.  Disulfiram, a Ferroptosis Inducer, Triggers Lysosomal Membrane Permeabilization by Up-Regulating ROS in Glioblastoma.

Authors:  Chen Qiu; Xin Zhang; Bin Huang; Shuai Wang; Wenjing Zhou; Chao Li; Xingang Li; Jian Wang; Ning Yang
Journal:  Onco Targets Ther       Date:  2020-10-20       Impact factor: 4.147

Review 4.  Yeast as a Model to Find New Drugs and Drug Targets for VPS13-Dependent Neurodegenerative Diseases.

Authors:  Joanna Kaminska; Piotr Soczewka; Weronika Rzepnikowska; Teresa Zoladek
Journal:  Int J Mol Sci       Date:  2022-05-04       Impact factor: 6.208

5.  Combination of Disulfiram and Copper-Cysteamine Nanoparticles for an Enhanced Antitumor Effect on Esophageal Cancer.

Authors:  Yan Chang; Fang Wu; Nil Kanatha Pandey; Lalit Chudal; Meiying Xing; Xiaoli Zhang; Linh Nguyen; Xian Liu; J Ping Liu; Wei Chen; Zui Pan
Journal:  ACS Appl Bio Mater       Date:  2020-09-09

6.  Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways.

Authors:  Yao Liu; Xin Guan; Meiling Wang; Naixue Wang; Yutong Chen; Baolei Li; Zhuxuan Xu; Fangwei Fu; Zhendong Zheng; Cheng Du
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

7.  Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines.

Authors:  Ammar Said Suliman; Mouhamad Khoder; Ibrahim Tolaymat; Matt Webster; Raid G Alany; Weiguang Wang; Abdelbary Elhissi; Mohammad Najlah
Journal:  Pharmaceutics       Date:  2021-01-10       Impact factor: 6.321

8.  Targeting Copper Homeostasis Improves Functioning of vps13Δ Yeast Mutant Cells, a Model of VPS13-Related Diseases.

Authors:  Piotr Soczewka; Déborah Tribouillard-Tanvier; Jean-Paul di Rago; Teresa Zoladek; Joanna Kaminska
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

Review 9.  Selective Targeting of Cancer Cells by Copper Ionophores: An Overview.

Authors:  Valentina Oliveri
Journal:  Front Mol Biosci       Date:  2022-03-04

Review 10.  Chemical Modulation of Gasdermin-Mediated Pyroptosis and Therapeutic Potential.

Authors:  Christopher B Ryder; Hannah C Kondolf; Meghan E O'Keefe; Bowen Zhou; Derek W Abbott
Journal:  J Mol Biol       Date:  2021-08-03       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.